Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg |
Synthetic nanodiscs offer a stable and biologically relevant environment that closely mimics cell membranes and enables full-length transmembrane humanCX3CR1 protein to be purified and analysed in vitro.
|
inquiry |
| ACPP-1182 | Recombinant Cynomolgus macaque Midkine Protein (Fc Tag) (AC1182) | 10 µg |
Recombinant Cynomolgus macaque Midkine Protein (Fc Tag) for SDS-PAGE
|
inquiry |
| ACPP-1183 | Recombinant Human GIPR Protein (Fc Tag) (AC1183) | 50 µg |
Recombinant Human GIPR Protein (Fc Tag) for SDS-PAGE
|
inquiry |
| ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg |
MSX1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg |
Fibroblast Growth Factor-Acidic Mouse Recombinant
|
inquiry |
| ACPP-1186 | Olig2 Blocking Peptide (AC1186) | 250 µg |
Olig2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg |
5HT1A Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1188 | GRIK1 Blocking Peptide (AC1188) | 250 µg |
GRIK1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1189 | PDE6C Blocking Peptide (AC1189) | 250 µg |
PDE6C Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg |
ADCY6 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg |
Nogo Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1192 | Human WNT3A Protein (AC1192) | 5 µg |
Wingless-Type MMTV Integration Site Family, Member 7A Human Recombinant
|
inquiry |
| ACPP-1193 | Human M2 Protein (AC1193) | 5 µg |
DLAT/DLST/BCOADC Recombinant Human
|
inquiry |
| ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg |
Calcium Sensing Receptor Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg |
CaMKII gamma Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.